ORIONS Money Stocks

[ADVFN_bioking]

ASRT..BIG risk guys read

Guys may be its better to avoid this stock there is some manufacturing risk so FDA likely to reject the drug .I dont know if they resolved that issue but i think its better to avoid the stock but its your own decision .GL

https://www.fool.com/earnings/call-transcripts/2019/08/08/assertio-therapeutics-inc-asrt-q2-2019-earnings-ca.aspx

With regard to our NDA filing for our long-acting cosyntropin for the diagnosis of adrenocortical insufficiency, our filing remains under active review, and we continue to move forward toward a scheduled PDUFA date of October 19. Our partner, West, the product supplier and IND holder, continues to investigate the manufacturing issue we discussed at our first-quarter earnings call.

The significance of these manufacturing models remains unclear. However, if these manufacturing issues are not resolved in a timely manner, it is possible this could impact cosyntropin approval, or if approved, we may not be able to launch the products until these issues are resolved.